About Us | A Letter from the Dean

Sheng Ding, Ph.D.
Dean of School of Pharmaceutical Sciences, Tsinghua University


Thank you for your interest in Tsinghua University's brand new School of Pharmaceutical Sciences (SPS), an initiative dedicated to developing innovative solutions to the world's most pressing disease issues. As I reflect on the rather short history of SPS, I feel great pride in the work we have accomplished, along with a sense of urgency as we work towards our vision of becoming a global leader in pharmaceutical innovation.   

In the past decade, the groundbreaking research conducted at academic institutes worldwide has catalyzed revolutionary advances in the biotech and pharmaceutical industries, enabling radical changes in many disease treatments. We, as educators and researchers at Tsinghua University - an institution renowned for its cutting-edge work in science and engineering - also aspire to develop therapeutic innovations, leading transformative advances in China's nascent biomedical industry, ultimately improving global health.  

The establishment of SPS in 2015 stemmed from the University's strong foundation in biomedical related disciplines, including life science, basic medical science, chemistry, biomedical engineering, chemical engineering, and material science. Since then, we have been actively recruiting outstanding researchers around the world and developing first-class translational platforms. To date, we have built a core faculty team of 27 Principal Investigators (PIs) who are advising over 200 undergraduates, graduate students, postdoctoral fellows, and research associates. Our outstanding faculty members have been recognized with national and international awards. In January 2016, SPS entered a partnership with the Bill & Melinda Gates Foundation to establish the Global Health Drug Discovery Institute (GHDDI) in Beijing, which aims to create a transformative drug discovery hub for global health.

Moving forward, we will continue expanding our faculty team in key frontiers of pharmaceutical science. Our research will focus on three themes: emerging basic biology with translational potential, enabling pharmaceutical technologies, and disease understanding and targeting. Advances in these areas will enable us to better understand, control, and cure diseases. We will work with our partners to build an ecosystem for pharmaceutical innovations. More importantly, we will strive to provide an excellent education to cultivate a new generation of pharmaceutical leaders, both in academia and industry.
As we embark on our journey of innovation and discovery, I am incredibly excited about the future that lies ahead for SPS. Through our passion, our unique approaches, and the strong support from our University, partners and advocates, I am confident we will lead the charge in creating new knowledge and transforming medicine.

June, 2016